SUMMARY
The transfusion of red blood cells (RBCs) is a well-established process, and currently, blood products are readily available in developed countries. Due to the everyday nature and relative safety of the process, clinicians may readily decide to transfuse RBCs. Patient blood management (PBM) programmes have led to a decrease in blood use in several locations (Gross et al., 2015; Meybohm et al., 2016; Leahy et al., 2017) . However, so far, there is no PBM programme in Finland.
Studies have shown variations in blood use among hospitals and clinicians (Palo et al., 2006; Abdelsattar et al., 2015) , indicating inappropriate blood use. The objective of RBC transfusion is to maintain adequate oxygen delivery to tissues, and the decision to transfuse cannot be based solely on laboratory parameters (Nielsen et al., 2017) . Nevertheless, blood haemoglobin (Hb) remains the primary measurement to monitor. Growing evidence and the newest guidelines for adult patients generally support a restrictive transfusion practice in which RBC transfusion is not indicated until the Hb level is below 7 g dL −1 in hospitalised haemodynamically stable, including critically ill, adult patients, whereas a threshold of 8 g dL −1 is recommended for patients undergoing orthopaedic surgery, cardiac surgery and those with pre-existing cardiovascular disease. For patients with acute ischaemic symptoms or severe thrombocytopenia, the desired Hb level may be higher, but it is generally not higher than 10 g dL −1 (National Blood Authority (NBA) Australia, 2013 , NICE UK, 2015 , Carson et al., 2016 .
Transfusions have been commonly given in even numbers without a scientific basis (Palo et al., 2006; Berger et al., 2012) , which may lead to excessive RBC use. It is now recommended to give one RBC unit at a time (commonly referred to as single-unit transfusion) and subsequently reassess (National Blood Authority (NBA) Australia, 2013) . Excess transfusions should be avoided due to costs and exposing recipients to adverse effects (Vamvakas & Blajchman, 2009 ). Moreover, misusing voluntarily donated human material is ethically problematic. Adopting a restrictive, instead of liberal, transfusion protocol has been shown in several patient groups to reduce blood use, at the same time not worsening outcomes (Hebert et al., 1999; Hajjar et al., 2010; Carson et al., 2011; Robertson et al., 2014; Mazer et al., 2017) . In the critically ill and patients with upper gastrointestinal bleeding, it may be beneficial to limit RBC transfusions to Hb < 7 g dL −1 (Villanueva et al., 2013; Salpeter et al., 2014) .
Many clinicians assume that the elderly need a higher Hb. This statement is also written in a Finnish guideline collection for physicians (Lauronen et al., 2016) . The latest international guidelines, however, do not recommend any higher Hb levels based on age (National Blood Authority (NBA) Australia, 2013). Overuse of medical interventions for the fragile elderly and for end-of-life patients has been claimed (Brownlee et al., 2017) ; thus, we analysed RBC use in these groups to detect possible overuse of RBC transfusion.
We aimed to scrutinise the current RBC transfusion practice regarding the number of RBCs given per population and trend over the study period, pre-and post-transfusion Hb -levels, the number of simultaneously transfused RBC units and demographics of the patients who received RBCs. We hypothesised that there would be a decreasing trend in RBC use and Hb levels over the study period.
MATERIALS AND METHODS
The study protocol was registry-based, retrospective and observational. All hospitals (n = 21) and primary care units in the Hospital District of Helsinki and Uusimaa were included, including university and regional hospitals, and all medical specialties were represented. The data set has a population base of approximately 1·6 million people, representing approximately 30% of the Finnish population. We included all RBC-transfused adult patients (age ≥ 16) over a 6-year period (2011) (2012) (2013) (2014) (2015) (2016) in the analysis. In Finland, all RBC products are leukoreduced and manufactured in the Finnish Red Cross (FRC) Blood Service. The manufacturing process and the content of RBC products have not changed during the study period. Standard RBC products comprise 96% of all transfused units and have an average Hb content of 49·8 (SD 4·7) g unit −1 . All transfused blood units are recorded in a blood bank computer system on a single-patient basis (Vertti, Mylab Oy, Tampere, Finland) , including patient demographics and the time of transfusion. In Finland, autologous transfusion is practiced only in the form of intraoperative cell salvage, which is not recorded in the data.
No patient identification data were handled. Patient-specific data included gender, age and blood type. Hospital specialty of admission was estimated based on the wards making the blood order. Information on patient diagnosis was not available.
The transfusion-specific data included the amount and type of blood product transfused, the medical unit making the blood order, the time of transfusion (specifically, the exact time when the RBC unit left the blood centre for transfusion), pre-transfusion Hb (as close to the moment of transfusion as possible and no values older than 24 h) and post-transfusion Hb (measured up to 1 week after transfusion). A transfusion event was defined as one or more RBC units simultaneously issued from the blood centre for a recipient. RBC units that were returned in the blood centre were never included in the data.
The calculation of transfused units per transfusion event was based on the exact time of when the RBC unit left the blood centre for transfusion. The calculation of red cell use per 1000 population was based on the study area population, including transfusions in all age groups at the end of each year. Transfusions for recipients living outside the study area were excluded for the calculation of red cell use per population. Hometown data were found for 90·0-91·5% of the recipients yearly. Data were missing if the recipient was not registered as a permanent resident in The Finnish Population Information System. Massive transfusion was defined as a transfusion of ≥10 RBC units per day (midnight to midnight). Calculation of transfusions for end-of-life patients (dying within 7 days of transfusion) included geriatric, palliative, cancer and haematology wards.
To coarsely estimate the adherence to international guidelines of RBC transfusion, we considered a pre-transfusion Hb ≥9·0 g dL −1 non-adherent because, in most guidelines, Hb > 9·0 g dL −1 is not considered necessary in any patient group. As a single-unit transfusion of RBCs is expected to elevate the blood Hb level by 1 g dL −1 , we chose a post-transfusion Hb ≥ 10·5 g dL −1 to indicate over-transfusion. We classified the data in several ways to enable separate observations of transfused individuals, transfusion events and all RBC products transfused. The data were compared to the FRC Blood Service database, demonstrating a 99·2% match in the RBC unit numbers.
Statistical analysis was performed with SPSS v·23 (IBM Corp., Armonk, NY, USA) and Microsoft Excel 2013 (Microsoft Corp., Redmond, WA, USA). We computed descriptive statistics for all transfusions and study variables. The results are reported as percentages (n), means (SD) or medians (IQR) accordingly. For continuous normally distributed variables, we used the t-test and anova with the Tukey post-test. Otherwise, we used non-parametric tests, the Mann-Whitney U test and the Kruskal-Wallis test. We compared yearly transfusion rates with the chi-square test. P values <0·05 were considered significant.
RESULTS

Number of administered RBCs
In total, 316 390 RBC units were transfused in 215 407 transfusion events for 58 492 single patients during 2011-2016 in the district (Fig. 1a) . Demographic and transfusion data are shown in Table 1 . The usage of RBCs decreased significantly each year from 34·9 units per 1000 population in 2011 to 27·5 units per 1000 population in 2016 (−21%, P < 0·001). The decline is seen in all ages and both genders, with a relatively greater decrease in females (Fig. 1b) . RBC consumption decreased in each medical field (as classified in Fig. 1c) , and the distribution of units in different medical fields during the whole study period is demonstrated in Fig. 1c . Most (62%) transfusions were single-unit, and the percentage of single-unit transfusions increased during the study period (Fig. 2) . The majority of patients (53%), however, altogether received two RBC units per 24 h. Only 4·2% of transfusions were multiple-unit (≥3) transfusions. Massive transfusions (≥ 10 units per day) were rare, 0·7% of events, and consumed 5·6% of all the RBC units. Of multiple-unit transfusions, 58% were given in even numbers.
Pre-and post-transfusion Hb levels
Of RBC-transfused patients, 85% had a preceding Hb value in the data within 24h. The median pre-transfusion Hb decreased during the study period; in 2011, it was 8·4 g dL −1 , and in 2016, it was 8·2 g dL −1 (P < 0·001). Post-transfusion Hb was captured for 92% of transfusions, and its median declined from 9·9 g dL −1 in 2011 to 9·6 g dL −1 in 2016 (P < 0·001). Figure 3 shows the yearly pre-transfusion Hb levels. Paired preand post-transfusion data were available for 81% of transfusions, and the median absolute Hb increase was 0·9 g dL −1 for single-unit transfusions and 1·6 g dL −1 for transfusions of two or more (≥ 2) units.
The median post-transfusion Hb was significantly higher in two or more unit transfusions compared to single-unit transfusions (9·9 vs 9·7 g dL −1 , P < 0·001). The percentage of patients with post-transfusion Hb ≥ 10·5 g dL −1 was 24·8% in single-unit transfusions, whereas it was 32·1% in transfusions of two or more units (P < 0·001).
The percentage of transfusions with pre-transfusion Hb ≥9·0 g dL −1 decreased during the study period from 29·5% in 2011 to 25·2% in 2016. Likewise, transfusions with a high post-transfusion Hb ≥10·5 g dL −1 decreased from 32·6% in 2011 to 22·3% in 2016. The medical units providing the most transfusions with pre-transfusion Hb ≥ 9·0 g dL −1 were located in tertiary care university hospitals (66%). The wards with the most events were the emergency room of a large university hospital, the cardiac surgical intensive care unit, the emergency ward of a trauma centre and the ward of vascular surgery, constituting 23% of transfusions with pre-transfusion Hb ≥ 9·0 g dL −1 . Of the RBCs administered with pre-transfusion Hb ≥ 9 g dL −1 , 9·7% were given in massive transfusions, whereas 59% went to patients receiving only 1-2 units per 24 h.
Demographics of the transfusion recipients
The majority of RBCs (60%) were transfused for surgical and critically ill patients (Fig. 1c) . The transfusion rate per population increased with age (Fig. 1b) , and the percentage of RBC recipients who were ≥ 80 years old was 24·4% (Table 1) . The median pre-transfusion Hb levels were higher in the age category of ≥80 years compared to younger patients, 8·4 g dL
and 8·2 g dL −1 , respectively (P < 0·001). In total, 2·1% of all transfused RBC units (n = 6003) were given to patients who died within a week of transfusion. The majority (62%) of the RBCs for dying patients were transfused in units treating critically ill, emergency and trauma patients. There were only 749 RBC units transfused during 6 years for end-of-life patients in geriatric and palliative care, constituting 0·2% of all transfused RBCs, and 12% of RBCs for patients who died within 1 week of transfusion.
DISCUSSION
Main results
Our results demonstrate a significant decline in RBC transfusion rate during the 6-year study period in southern Finland. The proportion of single unit transfusion has increased to 62%, and lower Hb levels have been accepted. Nevertheless, approximately one-quarter of RBC transfusions may be assessed as non-adherent to international guidelines with respect to Hb levels.
Decreasing trend
It had been previously estimated that RBC consumption would increase in Finland due to growing morbidity and increasing use of anticoagulant and antithrombotic medication (Fimea & Kela, 2015) . The population in the area has aged (Statistics Finland, 2017), and the area hospital statistics show an increased number of hospitalisations, intensive care unit admissions and increased or stable numbers of major surgery (data not shown). Despite these incremental healthcare performance demands, we observed that the RBC transfusion rate has decreased. Experts have credited PBM programmes for the decline observed in RBC transfusion rates in several countries recently (Carson et al., 2017) . However, in Finland, PBM principles have not been systematically practiced in the study area. Some intensive care units have established standard operational procedures regarding transfusion, but many Finnish units lack local guidelines.
We suggest several explanations for the decrease in RBC transfusion rate. These include enhanced surgical techniques, such as improved haemostasis and the use of systemic and local haemostatic agents to reduce blood loss. Mini-invasive procedures and endovascular surgery are progressively used. Intraoperative cell salvage is routinely utilised in major surgeries when substantial blood loss is expected. Synthetic colloids are no longer used, and intravenous fluids are administered more restrictively, minimising iatrogenic haemodilution. Moreover, the decrease in birth rate in Finland has reduced the consumption of RBCs in the fields of obstetrics and neonatology. The transfusion rate per population declined more in the female compared to male population not only in birth age but in other age categories as well (Fig. 1b) . The reason for this remained unexplained by our study. RBC consumption declined in each medical field (as classified in Fig. 1c) , suggesting that general awareness of adequate Hb levels and transfusion-associated adverse effects and costs have all likely increased. The significant decrease seen during the relatively short 6-year study period was evident both in the rate of transfusions per population and in the amount of RBC units per patient. The number of single-unit transfusions was significantly higher than before (Palo et al., 2006) and increased, showing growing adherence to evidence-based practice. Nevertheless, 34% of transfusions were still double-unit, and 58% of multiple-unit transfusions were given in even numbers. A national PBM programme could promote even more rational practice.
Hb levels
Although RBC transfusion is given to sustain oxygen delivery to tissues, the improvement of tissue oxygen levels may not be completely straightforward (Nielsen et al., 2017) . Indeed, damaged erythrocytes, cell waste and extracellular vesicles within the RBC products can cause microthrombi and impair vasodilation by scavenging nitrogen (Lee & Gladwin, 2010; Jy et al., 2011) . The optimal Hb trigger for transfusion in stable anaemic patients is largely unknown, and in many patient subgroups, it is based on expert opinion and tradition. Commonly, in Finland, patients are transfused at the latest when Hb falls below 8 g dL −1 , regardless of symptoms. This clinically observed general Hb limit is consistent with our study results, with a median pre-transfusion Hb of 8·2 g L −1 in 2016. Healthy individuals can tolerate considerably lower Hb levels at 5-6 g dL −1 (Weiskopf et al., 1998) . Most Finnish intensive care units have a transfusion trigger of Hb < 7 g dL −1 . Whether the commonly accepted lowest Hb level in Finland could become 7 g dL −1
instead of 8 g dL −1 in other medical fields as well remains to be seen. Maintaining a low Hb level safely requires regular monitoring of the patient for symptoms of anaemia and ischaemia, making it tempting to maintain the Hb level higher. Further randomised studies are required in several patient subgroups to prove the safety of the restrictive practice.
We observed a considerable number of transfusions with high pre-and post-transfusion Hb levels, and the majority of these can be estimated as non-adherent to guidelines with respect to Hb levels. We chose a pre-transfusion Hb > 9·0 g L −1 instead of a lower Hb limit to represent inappropriate transfusion in order to not overestimate the percentage of unnecessary transfusion. After all, the majority of RBC recipients were elderly surgical patients with a known high prevalence of ischaemic morbidities. Of the RBC units transfused with pre-transfusion Hb ≥ 9·0 g dL −1 , 9·7% were given in massive transfusions and, thus, were likely appropriate in most cases. During rapid bleeding, the patient has to be transfused based on clinical reasoning, and waiting for low blood Hb levels cannot be expected. Nevertheless, most RBC units (59%) transfused with pre-transfusion Hb ≥ 9·0 g dL −1 were administered to patients who received only 1-2 RBC units per 24 h, indicating non-urgent and likely inappropriate transfusion. The post-transfusion Hb was inappropriately high more commonly after transfusions of two or more units compared to single-unit transfusions.
We compared the findings of several recent international studies to our results. In a Spanish study of transfusions in emergency departments, the mean pre-transfusion Hb was 7·7 g dL −1 , and the mean post-transfusion Hb was 9·5 g dL −1 (Diaz et al., 2017) , which were lower than ours despite an emergency setting. In a large Danish tertiary hospital, pre-transfusion Hb was 8·4 g dL −1 , slightly higher than ours in 2016, whereas the percentage of single-unit transfusions was higher than in our data, 78% (Norgaard et al., 2017) . In an Australian study of tertiary hospitals, the pre-transfusion Hb was extremely low, 7·3 g dL −1 , consistent with Western Australia's transfusion rate of 19·4 per 1000 population, one of the lowest in the developed world (Leahy et al., 2017) . These international comparisons suggest that we may safely lower our RBC transfusion rate in Finland.
Demographics and transfusions for the elderly
The transfusion rate per population increased with age. The percentage of transfusions with inappropriately high preand post-transfusion Hb levels was higher for the elderly compared to recipients who were ≥ 80 years old. The evidence-based guidelines do not support a higher Hb target based on age (National Blood Authority (NBA) Australia, 2013), and a restrictive RBC transfusion practice seems safe for the elderly (Mazer et al., 2017) . Geriatric patients do have a higher prevalence of cardiovascular diseases, but Hb >9 g dL −1 is rarely needed. In Finland, the elderly are likely often transfused unnecessarily. However, we did not find notable over-transfusion in geriatric and palliative units for end-of-life patients. Most of the RBCs transfused to dying recipients were given in critical care units. There is always a number of critically ill or massively bleeding patients who will eventually die despite treatment, and in most cases, the transfusions in these patient groups cannot be considered inappropriate.
Strengths and limitations
Our study has several strengths. First, the study was based on a large, comprehensive and reliable database with data double-checked from the national Blood Service database. Second, our data covered all RBC transfusions in the entire capital area of Finland. Thus, we consider that our results have both internal and external validity. Finally, we are able to provide useful information for international comparisons from a country with high-quality healthcare (GBD 2016 Healthcare Access and Quality Collaborators, 2018).
However, there are several obvious limitations in our study. First, we had no information about patient medications, such as antithrombotic or anticoagulant drugs or comorbidities. These factors may influence transfusion decisions. Second, the retrospective nature of the study did not allow us to include clinical reasons for RBC transfusions. We could only evaluate the adherence of transfusion to guidelines based on Hb levels. Using Hb as a determinant for RBC transfusion can be criticised as it does not directly indicate tissue oxygenation levels and the presence of tissue hypoperfusion. Post-transfusion Hb is an especially limited indicator of appropriateness of transfusion as it is affected by many other factors than transfusion, such as disease states altering red cell turnover and bleeding. Finally, due to missing data, the transfusion rate per population may be slightly underestimated.
CONCLUSIONS
The RBC transfusion rate in southern Finland has decreased significantly. Most transfusions are performed in tertiary hospitals for surgical and critically ill patients. Our results indicate a trend towards more rational RBC use. Nevertheless, a considerable amount of transfusions non-adherent to international evidence-based guidelines may be avoided by a national PBM programme, continuing education and regular audits of RBC use. 
